Stock Events

Stock Events

Luye Pharma Group 

€0.31
1
+€0.02+8.45% Thursday 06:09

Statistics

Day High
0.27
Day Low
0.27
52W High
0.48
52W Low
0.2
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
27.6
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 20
€0.01
Sep 19
€0.01
Jul 19
€0.01
Sep 18
€0.01
Jun 18
€0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30MarExpected
Q2 2023
Q3 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Next
0
0.04
0.08
0.12
Expected EPS
0.0895730176
Actual EPS
N/A

Financials

7.75%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.59BRevenue
123.42MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LUP.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
HUTCHMED (China) Limited
HCM
Mkt Cap2.52B
Hutchison China MediTech, operates in the same region and focuses on innovative biopharmaceuticals, directly competing in Luye Pharma's market segments.
Zai Lab Limited
ZLAB
Mkt Cap2.91B
Zai Lab Limited, focuses on developing and commercializing a diverse range of healthcare products, including those in oncology and autoimmune diseases, similar to Luye Pharma.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech, although primarily known for vaccines, competes in the broader biopharmaceutical market in China, impacting Luye Pharma's market share.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline, a global pharmaceutical giant with a significant presence in China, offers products that compete across several of Luye Pharma's key therapeutic areas.
Novartis
NVS
Mkt Cap237.61B
Novartis, offers a broad range of healthcare products that compete directly with Luye Pharma's portfolio, especially in the oncology and neurology sectors.
Pfizer
PFE
Mkt Cap140.15B
Pfizer, operates globally and has a strong presence in China, competing with Luye Pharma in areas like oncology, neurology, and other pharmaceutical sectors.
Merck
MRK
Mkt Cap214.76B
Merck & Co., known for its wide range of pharmaceutical products, competes in the oncology and vaccine markets where Luye Pharma is also active.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb, competes in the global oncology market, directly affecting Luye Pharma's business in similar therapeutic areas.

About

Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally. The company offers Lipusu for ovarian cancer and carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Boyounuo, an injection for the treatment of various types of cancers; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; and Seroquel, Seroquel XR, Erzofri, Rivastigmine Multi-Day Transdermal Patch, and Rivastigmine. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; and Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation. Further, it offers Oukai; Meibirui; Jinyouping; and other products. The company distributes and sells pharmaceutical drugs; research and development of antibody drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.
Show more...
CEO
Mr. Dian Bo Liu
Employees
5115
Country
DE
ISIN
BMG570071099
WKN
000A116Z9

Listings

F
DE
LUP.F
HK
HK
2186.HK
OTC Link
US
LYPHF

0 Comments

Share your thoughts

FAQ

What is Luye Pharma Group stock price today?▼
The current price of LUP.F is €0.31 EUR — it has increased by +8.45% in the past 24 hours. Watch Luye Pharma Group stock price performance more closely on the chart.
What is Luye Pharma Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Luye Pharma Group stocks are traded under the ticker LUP.F.
Is Luye Pharma Group stock price growing?▼
LUP.F stock has risen by +17.56% compared to the previous week, the month change is a +15.79% rise, over the last year Luye Pharma Group has showed a +23.2% increase.
When is the next Luye Pharma Group earnings date?▼
Luye Pharma Group is going to release the next earnings report on August 27, 2026.
What is Luye Pharma Group revenue for the last year?▼
Luye Pharma Group revenue for the last year amounts to 1.59B EUR.
What is Luye Pharma Group net income for the last year?▼
LUP.F net income for the last year is 123.42M EUR.
Does Luye Pharma Group pay dividends?▼
Yes, LUP.F dividends are paid semi-annual. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Luye Pharma Group have?▼
As of April 05, 2026, the company has 5,115 employees.
In which sector is Luye Pharma Group located?▼
Luye Pharma Group operates in the Health Care sector.
When did Luye Pharma Group complete a stock split?▼
Luye Pharma Group has not had any recent stock splits.
Where is Luye Pharma Group headquartered?▼
Luye Pharma Group is headquartered in Yantai, DE.